e-learning
resources
Stockholm 2002
Monday 16.09.2002
Exercise and rehabilitation in patients with COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Mechanisms of improved exercise tolerance in COPD in response to tiotropium
D. E. O'Donnell, H. Magnussen, F. Gerken, S. Kesten, T. Fluege (Kingston, Canada; Grosshansdorf, Ingelheim, Germany; Ridgefield, United States Of America)
Source:
Annual Congress 2002 - Exercise and rehabilitation in patients with COPD
Session:
Exercise and rehabilitation in patients with COPD
Session type:
Thematic Poster Session
Number:
1826
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. E. O'Donnell, H. Magnussen, F. Gerken, S. Kesten, T. Fluege (Kingston, Canada; Grosshansdorf, Ingelheim, Germany; Ridgefield, United States Of America). Mechanisms of improved exercise tolerance in COPD in response to tiotropium. Eur Respir J 2002; 20: Suppl. 38, 1826
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Effect of formoterol on exercise tolerance in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 214s
Year: 2004
Budesonide/formoterol improves exercise tolerance compared with placebo and formoterol in COPD patients
Source: Annual Congress 2009 - Influence of interventions and comorbidity on exercise performance
Year: 2009
Effects of tiotropium and salmeterol/fluticasone combination on lung hyperinflation, dyspnea and exercise tolerance in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 33s
Year: 2006
Effects of tiotropium on neurohumoral activation during exercise in stable COPD patients
Source: Annual Congress 2009 - Next generation bronchodilators
Year: 2009
Comparative effects of formoterol monotherapy versus formoterol
plus
tiotropium on dynamic hyperinflation and exercise tolerance in COPD
Source: Annual Congress 2009 - Influence of interventions and comorbidity on exercise performance
Year: 2009
The impact of tiotropium for exercise induced bronchoconstriction
Source: International Congress 2017 – Bronchodilators and bronchoprotectors
Year: 2017
Six months treatment with salmeterol or ipratropium bromide improves effort tolerance and reduces dyspnoea but does not have any effect on lung function in COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 108s
Year: 2002
Efficacy of tiotropium and indacaterol alone or the combination on dynamic lung hyperinflation and exercise tolerance in COPD
Source: International Congress 2014 – Asthma and COPD management
Year: 2014
Impact of bronchodilator on pulmonary function and exercise tolerance in LAM
Source: Annual Congress 2011 - Lung and airway function
Year: 2011
Effects of tiotropium bromide on bronchial obstruction and exercise tolerance in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 213s
Year: 2006
LABA-LAMA combination is superior to LABA monotherapy in improving the cardiocirculatory responses to treadmill exercise in patients with moderate-to-severe COPD
Source: Annual Congress 2010 - Exercise in COPD
Year: 2010
Effects of inhaled formoterol on dynamic hyperinflation during and after incremental treadmill exercise in patients with advanced COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 172s
Year: 2006
Metronome-paced hyperventilation, CT measurements and exercise to investigate dynamic hyperinflation contrasting tiotropium versus indacaterol treatment in moderate COPD patients
Source: International Congress 2015 – Unravelling the mechanisms of symptoms and exercise limitationas in disease
Year: 2015
The inflammatory response to high doses of terbutaline during an acute exercise bout in patients with severe COPD
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013
Physiological determinants of reduced tolerance to interval exercise in moderate-to-severe COPD
Source: International Congress 2016 – Unmasking the mechanisms of symptoms and exercise limitation in disease
Year: 2016
Exercise tolerance with helium-hyperoxia versus hyperoxia in hypoxaemic patients with COPD
Source: Eur Respir J 2013; 42: 362-370
Year: 2013
Effect of a single dose of formoterol and tiotropium in exercise tolerance in COPD patients: preliminary data
Source: Eur Respir J 2003; 22: Suppl. 45, 405s
Year: 2003
Impact of exercise modality on exercise tolerance and functional capacity in patients with COPD
Source: Annual Congress 2010 - Pulmonary rehabilitation: understanding and developing the intervention
Year: 2010
Reversing acute bronchoconstriction in asthma: the effect of bronchodilator tolerance after treatment with formoterol
Source: Eur Respir J 2001; 17: 368-373
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept